These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14971906)

  • 21. Determination of the binding mode of thienopyrimidinedione antagonists to the human gonadotropin releasing hormone receptor using structure-activity relationships, site-directed mutagenesis, and homology modeling.
    Betz SF; Lio FM; Gao Y; Reinhart GJ; Guo Z; Mesleh MF; Zhu YF; Struthers RS
    J Med Chem; 2006 Oct; 49(21):6170-6. PubMed ID: 17034124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of a thieno[2,3-d]pyrimidine-2,4-dione bearing a p-methoxyureidophenyl moiety at the 6-position: a highly potent and orally bioavailable non-peptide antagonist for the human luteinizing hormone-releasing hormone receptor.
    Sasaki S; Cho N; Nara Y; Harada M; Endo S; Suzuki N; Furuya S; Fujino M
    J Med Chem; 2003 Jan; 46(1):113-24. PubMed ID: 12502365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of a novel, orally active, small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist.
    Li H; Anderes KL; Kraynov EA; Luthin DR; Do QQ; Hong Y; Tompkins E; Sun ET; Rajapakse R; Pathak VP; Christie LC; Feng J; Vazir H; Castillo R; Gregory ML; Castro M; Nared-Hood K; Paderes G; Anderson MB
    J Med Chem; 2006 Jun; 49(11):3362-7. PubMed ID: 16722655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of piperazinyl heterocyclic antagonists of the gonadotropin releasing hormone (GnRH) receptor.
    Vera MD; Lundquist JT; Chengalvala MV; Cottom JE; Feingold IB; Garrick LM; Green DM; Hauze DB; Mann CW; Mehlmann JF; Rogers JF; Shanno L; Wrobel JE; Pelletier JC
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2512-5. PubMed ID: 20236823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel synthesis of 2-arylpyrrolo[1,2-a]pyrimid-7-ones and their structure-activity relationships as potent GnRH receptor antagonists.
    Zhu YF; Wilcoxen K; Saunders J; Guo Z; Gao Y; Connors PJ; Gross TD; Tucci FC; Struthers RS; Reinhart GJ; Xie Q; Chen C
    Bioorg Med Chem Lett; 2002 Feb; 12(3):403-6. PubMed ID: 11814807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
    Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
    Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel synthesis of 7-aryl-8-fluoro-pyrrolo[1,2-a]pyrimid-4-ones as potent, stable GnRH receptor antagonists.
    Tucci FC; Zhu YF; Guo Z; Gross TD; Connors PJ; Struthers RS; Reinhart GJ; Wang X; Saunders J; Chen C
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3491-5. PubMed ID: 12419391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small molecule antagonists of the gonadotropin-releasing hormone (GnRH) receptor: structure-activity relationships of small heterocyclic groups appended to the 2-phenyl-4-piperazinyl-benzimidazole template.
    Hauze DB; Chengalvala MV; Cottom JE; Feingold IB; Garrick L; Green DM; Huselton C; Kao W; Kees K; Lundquist JT; Mann CW; Mehlmann JF; Rogers JF; Shanno L; Wrobel J; Pelletier JC
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1986-90. PubMed ID: 19251413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of aryl-1,2,4-triazine-3,5-diones as antagonists of the gonadotropin-releasing hormone receptor.
    Pontillo J; Guo Z; Wu D; Struthers RS; Chen C
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4363-6. PubMed ID: 16046130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overlapping, nonidentical binding sites of different classes of nonpeptide antagonists for the human gonadotropin-releasing hormone receptor.
    Betz SF; Reinhart GJ; Lio FM; Chen C; Struthers RS
    J Med Chem; 2006 Jan; 49(2):637-47. PubMed ID: 16420049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and structure-activity relationships of novel imidazolo[1,2-a]pyrimid-5-ones as potent GnRH receptor antagonists.
    Gross TD; Zhu YF; Saunders J; Wilcoxen KM; Gao Y; Connors PJ; Guo Z; Struthers RS; Reinhart GJ; Chen C
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2185-7. PubMed ID: 12127533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zwitterionic uracil derivatives as potent GnRH receptor antagonists with improved pharmaceutical properties.
    Regan CF; Guo Z; Chen Y; Huang CQ; Chen M; Jiang W; Rueter JK; Coon T; Chen C; Saunders J; Brown MS; Betz SF; Struthers RS; Yang C; Wen J; Madan A; Zhu YF
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4503-7. PubMed ID: 18667310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and structure-activity relationships of thieno[2,3-b]pyridin-4-one derivatives as a novel class of potent, orally active, non-peptide luteinizing hormone-releasing hormone receptor antagonists.
    Imada T; Cho N; Imaeda T; Hayase Y; Sasaki S; Kasai S; Harada M; Matsumoto H; Endo S; Suzuki N; Furuya S
    J Med Chem; 2006 Jun; 49(13):3809-25. PubMed ID: 16789738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and structure-activity relationships of thieno[2,3-b]pyrroles as antagonists of the GnRH receptor.
    Arnould JC; Delouvrié B; Boutron P; Dossetter AG; Foote KM; Hamon A; Hancox U; Harris CS; Hutton M; Lamorlette M; Matusiak Z
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6448-54. PubMed ID: 17937987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 2. Synthesis, chirality, and pharmacokinetics.
    Borthwick AD; Davies DE; Exall AM; Livermore DG; Sollis SL; Nerozzi F; Allen MJ; Perren M; Shabbir SS; Woollard PM; Wyatt PG
    J Med Chem; 2005 Nov; 48(22):6956-69. PubMed ID: 16250654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling.
    Frølund B; Jensen LS; Guandalini L; Canillo C; Vestergaard HT; Kristiansen U; Nielsen B; Stensbøl TB; Madsen C; Krogsgaard-Larsen P; Liljefors T
    J Med Chem; 2005 Jan; 48(2):427-39. PubMed ID: 15658856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 1. Structure-activity relationships and optimization of heterocyclic substituents.
    Slee DH; Chen Y; Zhang X; Moorjani M; Lanier MC; Lin E; Rueter JK; Williams JP; Lechner SM; Markison S; Malany S; Santos M; Gross RS; Jalali K; Sai Y; Zuo Z; Yang C; Castro-Palomino JC; Crespo MI; Prat M; Gual S; Díaz JL; Saunders J
    J Med Chem; 2008 Mar; 51(6):1719-29. PubMed ID: 18307292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allosteric and orthosteric binding modes of two nonpeptide human gonadotropin-releasing hormone receptor antagonists.
    Sullivan SK; Brown MS; Gao Y; Loweth CJ; Lio FM; Crowe PD; Struthers RS; Betz SF
    Biochemistry; 2006 Dec; 45(51):15327-37. PubMed ID: 17176055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel gonadotropin-releasing hormone antagonists with substitutions at position 5.
    Samant MP; Hong DJ; Croston G; Rivier C; Rivier J
    Biopolymers; 2005; 80(2-3):386-91. PubMed ID: 15614806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chains.
    Zhou HB; Sheng S; Compton DR; Kim Y; Joachimiak A; Sharma S; Carlson KE; Katzenellenbogen BS; Nettles KW; Greene GL; Katzenellenbogen JA
    J Med Chem; 2007 Jan; 50(2):399-403. PubMed ID: 17228884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.